Back to Search Start Over

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.

Authors :
Little JS
Dedrick RM
Freeman KG
Cristinziano M
Smith BE
Benson CA
Jhaveri TA
Baden LR
Solomon DA
Hatfull GF
Source :
Nature communications [Nat Commun] 2022 May 03; Vol. 13 (1), pp. 2313. Date of Electronic Publication: 2022 May 03.
Publication Year :
2022

Abstract

Mycobacterium chelonae is a rare cause of chronic disseminated cutaneous infections in immunocompromised patients. Multidrug-resistant M. chelonae infections present a challenge for treatment, and prolonged antimicrobial courses lead to significant toxicities and further antimicrobial resistance. We report a case of refractory cutaneous disseminated M. chelonae infection in a patient with seronegative arthritis on immunotherapy with tofacitinib that was treated with combination antimicrobial, surgical, and single bacteriophage therapy with excellent clinical response. The patient developed neutralizing antibodies against the bacteriophage but continues to have stable improvement of disease with negative biopsies and no evidence of bacterial resistance to the phage.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
13
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
35504908
Full Text :
https://doi.org/10.1038/s41467-022-29689-4